Strattera
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant option that raises norepinephrine levels in the brain.
All strengths and pack prices
| Strength | Pack | Price | Per unit |
|---|---|---|---|
| 10mg | 10 capsules | $64.00 | $6.40 |
| 10mg | 20 capsules | $72.00 | $3.60 |
| 10mg | 30 capsules | $80.00 | $2.67 |
| 10mg | 60 capsules | $88.00 | $1.47 |
| 10mg | 90 capsules | $96.00 | $1.07 |
| 10mg | 120 capsules | $111.00 | $0.93 |
| 10mg | 180 capsules | $159.00 | $0.88 |
| 10mg | 270 capsules | $230.00 | $0.85 |
| 10mg | 360 capsules | $286.00 | $0.79 |
| 18mg | 10 capsules | $66.00 | $6.60 |
| 18mg | 20 capsules | $73.00 | $3.65 |
| 18mg | 30 capsules | $81.00 | $2.70 |
| 18mg | 60 capsules | $102.00 | $1.70 |
| 18mg | 90 capsules | $146.00 | $1.62 |
| 18mg | 120 capsules | $190.00 | $1.58 |
| 18mg | 180 capsules | $263.00 | $1.46 |
| 18mg | 270 capsules | $364.00 | $1.35 |
| 18mg | 360 capsules | $459.00 | $1.28 |
| 25mg | 10 capsules | $68.00 | $6.80 |
| 25mg | 20 capsules | $75.00 | $3.75 |
| 25mg | 30 capsules | $82.00 | $2.73 |
| 25mg | 60 capsules | $123.00 | $2.05 |
| 25mg | 90 capsules | $177.00 | $1.97 |
| 25mg | 120 capsules | $218.00 | $1.82 |
| 25mg | 180 capsules | $272.00 | $1.51 |
| 25mg | 270 capsules | $368.00 | $1.36 |
| 25mg | 360 capsules | $408.00 | $1.13 |
| 40mg | 10 capsules | $68.00 | $6.80 |
| 40mg | 20 capsules | $79.00 | $3.95 |
| 40mg | 30 capsules | $124.00 | $4.13 |
| 40mg | 60 capsules | $224.00 | $3.73 |
| 40mg | 90 capsules | $292.00 | $3.24 |
| 40mg | 120 capsules | $336.00 | $2.80 |
| 40mg | 180 capsules | $437.00 | $2.43 |
| 40mg | 270 capsules | $504.00 | $1.87 |
| 40mg | 360 capsules | $560.00 | $1.56 |
- Category
- ADHD & Focus
- Active ingredient
- Atomoxetine
- Route
- Oral use
- Form
- Tablet
- Strengths
- 10mg · 18mg · 25mg · 40mg
This listing uses Strattera as a reference name. A generic equivalent is supplied; its exact brand and manufacturer are confirmed before supply.
Strattera details
- Alternative names
- atomoxetine
- Therapeutic class
- Selective Norepinephrine Reuptake Inhibitor (SNRI)
- Pharmacological class
- Non-Stimulant ADHD Agent
- Known off-label uses
- narcolepsy
- Contraindications
- narrow-angle glaucoma; pheochromocytoma; concurrent or recent MAO inhibitor use
- Minor side effects
- nausea; decreased appetite; somnolence
- Moderate side effects
- dry mouth; erectile dysfunction; insomnia
- Dosage forms
- Tablet
- Administration route
- Oral use
- Originator
- Eli Lilly
- Onset time
- 2–4 weeks
- Duration
- 24 hours
- Storage instructions
- Store below 25°C.
- Drug interactions
- MAO Inhibitors; Fluoxetine; Paroxetine
- Age restrictions
- Approved for children over six years, adolescents, and adults.
Serious side effects
suicidal ideation, requires immediate medical attention; severe hepatotoxicity, requires immediate medical attention
Patient summary
Atomoxetine tablets for attention deficit hyperactivity disorder. It is a non-stimulant option that raises norepinephrine levels in the brain.
Mechanism of action
Selectively inhibits the presynaptic norepinephrine transporter, increasing extracellular transmitter levels in the prefrontal cortex.
Pregnancy and breastfeeding
Pregnancy: Use if potential benefit exceeds risk. Breastfeeding: Consult a doctor.
What you will receive
Strattera is used here as a reference originator brand name to identify the medicine. We are not affiliated with the brand owner, and this listing does not offer the originator product.
- The supplied product is a generic equivalent containing Atomoxetine, not the originator brand shown as the reference.
- The exact generic brand, manufacturer and dispatch location are confirmed based on the product, destination and available manufacturer or partner warehouse.
- Check the final product details at checkout before confirming an order.